Human primary immunodeficiency caused by expression of a kinase-dead p110? mutant - 07/02/19
Doi : 10.1016/j.jaci.2018.10.005
Sarah Beaussant Cohen, MD a, Wayne Bainter, MMSc a, Jared L. Johnson, PhD b, Ting-Yu Lin, MS b, Jenny C.Y. Wong, MS b, Jacqueline G. Wallace, BS a, Jennifer Jones, BA a, Sonia Qureshi, MD c, Fatima Mir, MD c, Farah Qamar, MD c, Lewis C. Cantley, PhD b, Raif S. Geha, MD a, Janet Chou, MD a 
a Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass
b Meyer Cancer Center, Weill Cornell Medicine, New York, NY
c Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan
| This study was supported by grant number 5T32AI007512-33 (S.B.C.), grant number NCI R35 CA197588 (L.C.C.), grant number 5K08AI116979-04 (J.C.), grant number 1R01AI139633-01 (R.S.G.), and the Perkin Fund (R.S.G.). |
|
| Disclosure of potential conflict of interest: L. C. Cantley is a founder and member of the SAB of Agios Pharmaceuticals and of Petra Pharmaceuticals. L. C. Cantley's laboratory receives financial support from Petra Pharmaceuticals. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 2
P. 797 - février 2019 Retour au numéro
Article précédent
- Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation
- Thomas Bärnthaler, Katharina Jandl, Heinz Sill, Barbara Uhl, Yannick Schreiber, Magdalena Grill, Dominique Thomas, Rudolf Schicho, Gunther Marsche, Saša Frank, Akos Heinemann, Rufina Schuligoi
- Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease
- Katherine N. Cahill, Katherine Murphy, Joseph Singer, Elliot Israel, Joshua A. Boyce, Tanya M. Laidlaw
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?